Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arteries | 4 | 2009 | 81 | 1.040 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 164 | 0.650 |
Why?
|
| Blood Pressure | 5 | 2014 | 662 | 0.530 |
Why?
|
| Menarche | 1 | 2015 | 15 | 0.460 |
Why?
|
| Cardiovascular Diseases | 4 | 2009 | 729 | 0.420 |
Why?
|
| Tunica Media | 3 | 2008 | 14 | 0.410 |
Why?
|
| Vascular Resistance | 3 | 2009 | 37 | 0.380 |
Why?
|
| Age Factors | 2 | 2015 | 1139 | 0.370 |
Why?
|
| Premature Birth | 2 | 2011 | 94 | 0.370 |
Why?
|
| Tunica Intima | 2 | 2008 | 21 | 0.350 |
Why?
|
| Infant, Low Birth Weight | 2 | 2011 | 36 | 0.340 |
Why?
|
| Fetal Organ Maturity | 1 | 2010 | 3 | 0.330 |
Why?
|
| Adult | 15 | 2025 | 13458 | 0.300 |
Why?
|
| Louisiana | 5 | 2010 | 49 | 0.300 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2008 | 12 | 0.290 |
Why?
|
| Bilirubin | 1 | 2008 | 19 | 0.280 |
Why?
|
| Carotid Artery Diseases | 1 | 2008 | 25 | 0.280 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2008 | 74 | 0.280 |
Why?
|
| Angiotensinogen | 1 | 2007 | 6 | 0.280 |
Why?
|
| Carotid Artery, Common | 1 | 2007 | 9 | 0.280 |
Why?
|
| Female | 18 | 2025 | 24018 | 0.250 |
Why?
|
| Pulsatile Flow | 1 | 2006 | 28 | 0.250 |
Why?
|
| Radial Artery | 2 | 2020 | 3 | 0.250 |
Why?
|
| Risk Factors | 9 | 2020 | 3942 | 0.240 |
Why?
|
| Femoral Artery | 2 | 2020 | 12 | 0.230 |
Why?
|
| Humans | 20 | 2025 | 42163 | 0.220 |
Why?
|
| Compliance | 3 | 2009 | 14 | 0.210 |
Why?
|
| Young Adult | 5 | 2025 | 4936 | 0.210 |
Why?
|
| Depression | 2 | 2021 | 837 | 0.210 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1020 | 0.200 |
Why?
|
| Cholesterol, HDL | 2 | 2021 | 99 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 860 | 0.200 |
Why?
|
| Male | 13 | 2025 | 22779 | 0.200 |
Why?
|
| Carotid Arteries | 2 | 2015 | 35 | 0.180 |
Why?
|
| Quarantine | 1 | 2021 | 8 | 0.170 |
Why?
|
| HIV Infections | 4 | 2025 | 2535 | 0.170 |
Why?
|
| Mass Screening | 1 | 2025 | 531 | 0.170 |
Why?
|
| Adolescent | 4 | 2025 | 5950 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2011 | 112 | 0.150 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2011 | 229 | 0.140 |
Why?
|
| Gene Frequency | 2 | 2008 | 203 | 0.140 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 242 | 0.130 |
Why?
|
| Competitive Behavior | 1 | 2017 | 15 | 0.130 |
Why?
|
| Running | 1 | 2017 | 13 | 0.130 |
Why?
|
| Religion and Medicine | 1 | 2017 | 20 | 0.130 |
Why?
|
| Mental Health | 1 | 2021 | 363 | 0.130 |
Why?
|
| Walking | 1 | 2017 | 85 | 0.120 |
Why?
|
| Genotype | 2 | 2008 | 796 | 0.110 |
Why?
|
| Tuberculosis | 1 | 2015 | 76 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 311 | 0.110 |
Why?
|
| Anxiety | 1 | 2021 | 847 | 0.100 |
Why?
|
| Child | 1 | 2021 | 3381 | 0.100 |
Why?
|
| Middle Aged | 7 | 2025 | 11819 | 0.090 |
Why?
|
| Protease Inhibitors | 1 | 2011 | 53 | 0.090 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 188 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2011 | 2485 | 0.090 |
Why?
|
| Birth Weight | 1 | 2011 | 94 | 0.090 |
Why?
|
| Models, Biological | 1 | 2014 | 711 | 0.080 |
Why?
|
| Pregnancy | 3 | 2011 | 1737 | 0.080 |
Why?
|
| New Orleans | 1 | 2010 | 17 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2011 | 960 | 0.080 |
Why?
|
| Muscle Tonus | 1 | 2009 | 6 | 0.080 |
Why?
|
| United States | 1 | 2021 | 5072 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2010 | 108 | 0.080 |
Why?
|
| Cesarean Section | 1 | 2009 | 63 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2009 | 253 | 0.070 |
Why?
|
| HTLV-II Infections | 1 | 2007 | 6 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 200 | 0.070 |
Why?
|
| HTLV-I Infections | 1 | 2007 | 33 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2007 | 132 | 0.070 |
Why?
|
| Lung | 1 | 2010 | 484 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 8 | 0.060 |
Why?
|
| Sex Factors | 1 | 2009 | 1008 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2008 | 199 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 207 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2007 | 164 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 350 | 0.060 |
Why?
|
| Southeastern United States | 1 | 2025 | 58 | 0.060 |
Why?
|
| Health | 1 | 2005 | 30 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2009 | 1729 | 0.060 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2025 | 77 | 0.060 |
Why?
|
| Mississippi | 2 | 2015 | 129 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 727 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2008 | 990 | 0.050 |
Why?
|
| HIV-1 | 1 | 2007 | 747 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2005 | 916 | 0.040 |
Why?
|
| Hypertension | 1 | 2007 | 823 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2020 | 55 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 3077 | 0.040 |
Why?
|
| Aged | 2 | 2020 | 7982 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 1586 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 1848 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 29 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 733 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 169 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 146 | 0.030 |
Why?
|
| Urban Population | 1 | 2015 | 364 | 0.030 |
Why?
|
| Motivation | 1 | 2017 | 492 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2014 | 386 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 2803 | 0.020 |
Why?
|
| Chorioamnionitis | 1 | 2009 | 5 | 0.020 |
Why?
|
| Employment | 1 | 2010 | 83 | 0.020 |
Why?
|
| Morbidity | 1 | 2009 | 97 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 362 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 512 | 0.020 |
Why?
|
| Educational Status | 1 | 2010 | 335 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 574 | 0.020 |
Why?
|
| Genes, pX | 1 | 2007 | 3 | 0.020 |
Why?
|
| CD4-CD8 Ratio | 1 | 2007 | 30 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2007 | 75 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 1001 | 0.020 |
Why?
|
| Viral Load | 1 | 2007 | 344 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2007 | 323 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2007 | 1574 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 1265 | 0.010 |
Why?
|